Colossal Biosciences Secures $150M Series B and Announces Plan to De-Extinct the Iconic Dodo
Following massive progress on the Woolly Mammoth and Tasmanian tiger, Colossal launches Avian Genomics Group to continue groundbreaking de-extinction pursuits DALLAS–(BUSINESS WIRE)–Colossal Biosciences, the world’s first de-extinction company, has today announced an oversubscribed $150M Series B financing led by United...